CCL

Összesen 7 találat.
#/oldal:
Részletezés:
Rendezés:

1.

001-es BibID:BIBFORM082344
Első szerző:Butts, Charles
Cím:Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START) : a randomised, double-blind, phase 3 trial / Charles Butts, Mark A. Socinski, Paul L. Mitchell, Nick Thatcher, Libor Havel, Maciej Krzakowski, Sergiusz Nawrocki, Tudor-Eliade Ciuleanu, Lionel Bosquée, José Manuel Trigo, Alexander Spira, Lise Tremblay, Jan Nyman, Rodryg Ramlau, Gun Wickart-Johansson, Peter Ellis, Oleg Gladkov, José Rodrigues Pereira, Wilfried Ernst Erich Eberhardt, Christoph Helwig, Andreas Schröder, Frances A. Shepherd, START trial team
Dátum:2014
ISSN:1470-2045
Megjegyzések:BACKGROUND: Effective maintenance therapies after chemoradiotherapy for lung cancer are lacking. Our aim was to investigate whether the MUC1 antigen-specific cancer immunotherapy tecemotide improves survival in patients with stage III unresectable non-small-cell lung cancer when given as maintenance therapy after chemoradiation. METHODS: The phase 3 START trial was an international, randomised, double-blind trial that recruited patients with unresectable stage III non-small-cell lung cancer who had completed chemoradiotherapy within the 4-12 week window before randomisation and received confirmation of stable disease or objective response. Patients were stratified by stage (IIIA vs IIIB), response to chemoradiotherapy (stable disease vs objective response), delivery of chemoradiotherapy (concurrent vs sequential), and region using block randomisation, and were randomly assigned (2:1, double-blind) by a central interactive voice randomisation system to either tecemotide or placebo. Injections of tecemotide (806 ?g lipopeptide) or placebo were given every week for 8 weeks, and then every 6 weeks until disease progression or withdrawal. Cyclophosphamide 300 mg/m(2) (before tecemotide) or saline (before placebo) was given once before the first study drug administration. The primary endpoint was overall survival in a modified intention-to-treat population. This study is registered with ClinicalTrials.gov, number NCT00409188. FINDINGS: From Feb 22, 2007, to Nov 15, 2011, 1513 patients were randomly assigned (1006 to tecemotide and 507 to placebo). 274 patients were excluded from the primary analysis population as a result of a clinical hold, resulting in analysis of 829 patients in the tecemotide group and 410 in the placebo group in the modified intention-to-treat population. Median overall survival was 25.6 months (95% CI 22.5-29.2) with tecemotide versus 22.3 months (19.6-25.5) with placebo (adjusted HR 0.88, 0.75-1.03; p=0.123). In the patients who received previous concurrent chemoradiotherapy, median overall survival for the 538 (65%) of 829 patients assigned to tecemotide was 30.8 months (95% CI 25.6-36.8) compared with 20.6 months (17.4-23.9) for the 268 (65%) of 410 patients assigned to placebo (adjusted HR 0.78, 0.64-0.95; p=0.016). In patients who received previous sequential chemoradiotherapy, overall survival did not differ between the 291 (35%) patients in the tecemotide group and the 142 (35%) patients in the placebo group (19.4 months [95% CI 17.6-23.1] vs 24.6 months [18.8-33.0], respectively; adjusted HR 1.12, 0.87-1.44; p=0.38). Grade 3-4 adverse events seen with a greater than 2% frequency with tecemotide were dyspnoea (49 [5%] of 1024 patients in the tecemotide group vs 21 [4%] of 477 patients in the placebo group), metastases to central nervous system (29 [3%] vs 6 [1%]), and pneumonia (23 [2%] vs 12 [3%]). Serious adverse events with a greater than 2% frequency with tecemotide were pneumonia (30 [3%] in the tecemotide group vs 14 [3%] in the placebo group), dyspnoea (29 [3%] vs 13 [3%]), and metastases to central nervous system (32 [3%] vs 9 [2%]). Serious immune-related adverse events did not differ between groups. INTERPRETATION: We found no significant difference in overall survival with the administration of tecemotide after chemoradiotherapy compared with placebo for all patients with unresectable stage III non-small-cell lung cancer. However, tecemotide might have a role for patients who initially receive concurrent chemoradiotherapy, and further study in this population is warranted.
Tárgyszavak:Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban
folyóiratcikk
Megjelenés:Lancet Oncology. - 15 : 1 (2014), p. 59-68. -
További szerzők:Socinski, Mark A. Mitchell, Paul Thatcher, Nick Havel, Libor Krzakowski, Maciej Nawrocki, Sergiusz Ciuleanu, Tudor Bosquee, Lionel Trigo, José Manuel Spira, Alexander Tremblay, Lise Nyman, Jan Ramlau, Rodryg Wickart-Johansson, Gun Ellis, Peter Gladkov, Oleg Pereira, José Rodrigues Eberhardt, Wilfried Ernst Erich Helwig, Christoph Schröder, Andreas Shepherd, Frances A. Bittner Nóra (1963-) (orvos) START trial team
Internet cím:Intézményi repozitóriumban (DEA) tárolt változat
Borító:

2.

001-es BibID:BIBFORM081819
Első szerző:Fuchs, Charles S.
Cím:Ramucirumab with cisplatin and fluoropyrimidine as first-line therapy in patients with metastatic gastric or junctional adenocarcinoma (RAINFALL) : a double-blind, randomised, placebo-controlled, phase 3 trial / Fuchs Charles S., Shitara Kohei, Di Bartolomeo Maria, Lonardi Sara, Al-Batran Salah-Eddin, Van Cutsem Eric, Ilson David H., Alsina Maria, Chau Ian, Lacy Jill, Ducreux Michel, Mendez Guillermo Ariel, Alavez Alejandro Molina, Takahari Daisuke, Mansoor Wasat, Enzinger Peter C., Gorbounova Vera, Wainberg Zev A., Hegewisch-Becker Susanna, Ferry David, Lin Ji, Carlesi Roberto, Das Mayukh, Shah Manish A., RAINFALL Study Group
Dátum:2019
ISSN:1470-2045
Tárgyszavak:Orvostudományok Elméleti orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban
folyóiratcikk
Megjelenés:Lancet Oncology. - 20 : 3 (2019), p. 420-435. -
További szerzők:Shitara, Kohei Di Bartolomeo, Maria Lonardi, Sara Al-Batran, Salah-Eddin Van Cutsem, Eric Ilson, David H. Alsina, Maria Chau, Ian Lacy, Jill Ducreux, Michel Mendez, Guillermo Ariel Alavez, Alejandro Molina Takahari, Daisuke Mansoor, Wasat Enzinger, Peter C. Gorbounova, Vera Wainberg, Zev A. Hegewisch-Becker, Susanna Ferry, David Lin, Ji Carlesi, Roberto Das, Mayukh Shah, Manish A. András Csilla (1961-) (onkológus szakorvos) RAINFALL Study Group
Internet cím:Szerző által megadott URL
DOI
Intézményi repozitóriumban (DEA) tárolt változat
Borító:

3.

001-es BibID:BIBFORM008928
Első szerző:Klug, Stefani J.
Cím:TP53 codon 72 polymorphism and cervical cancer : a pooled analysis of individual data from 49 studies / Klug Stefani J., Ressing Meike, Koenig Jochem, Abba Martin C., Agorastos Theodoros, Brenna Sylvia M. F., Ciotti Marco, Das B. R., Del Mistro Annarosa, Dybikowska Aleksandra, Giuliano Anna R., Gudleviciene Zivile, Gyllensten Ulf, Haws Andrea L. F., Helland Aslaug, Herrington C. Simon, Hildesheim Alan, Humbey Oliver, Jee Sun H., Kim Jae Weon, Madeleine M. Margaret, Menczer Joseph, Ngan Hextan Y. S. N., Nishikawa Akira, Niwa Yosimitshu, Pegoraro Rosemary, Pillai M. R., Ranzani Gulielmina, Rezza Giovanni, Rosenthal Adam N., Roychoudhury Susanta, Saranath Dhananjaya, Schmitt Virginia M., Sengupta Sharmila, Settheetham-Ishida Wannapa, Shirasawa Hiroshi, Snijders Peter J. F., Stoler Mark H., Suárez-Rincón Angel E., Szarka Krisztina, Tachezy Ruth, Ueda Masatsugu, van der Zee Ate G. J., von Knebel Doeberitz Magnus, Wu Ming-Tsang, Yamashita Tsuyoshi, Zehbe Ingeborg, Blettner Maria
Dátum:2009
Megjegyzések:Summary Background Cervical cancer is caused primarily by human papillomaviruses (HPV). The polymorphism rs1042522 at codon 72 of the TP53 tumour-suppressor gene has been investigated as a genetic cofactor. More than 80 studies were done between 1998 and 2006, after it was initially reported that women who are homozygous for the arginine allele had a risk for cervical cancer seven times higher than women who were heterozygous for the allele. However, results have been inconsistent. Here we analyse pooled data from 49 studies to determine whether there is an association between TP53 codon 72 polymorphism and cervical cancer. Methods Individual data on 7946 cases and 7888 controls from 49 diff erent studies worldwide were reanalysed. Odds ratios (OR) were estimated using logistic regression, stratifying by study and ethnic origin. Subgroup analyses were done for infection with HPV, ethnic origin, Hardy-Weinberg equilibrium, study quality, and the material used to determine TP53 genotype. Findings The pooled estimates (OR) for invasive cervical cancer were 1.22 (95% CI 1.08-1.39) for arginine homozygotes compared with heterozygotes, and 1.13 (0.94-1.35) for arginine homozygotes versus proline homozygotes. Subgroup analyses showed signifi cant excess risks only in studies where controls were not in Hardy-Weinberg equilibrium (1.71 [1.21-2.42] for arginine homozygotes compared with heterozygotes), in non-epidemiological studies (1.35 [1.15-1.58] for arginine homozygotes compared with heterozygotes), and in studies where TP53 genotype was determined from tumour tissue (1.39 [1.13-1.73] for arginine homozygotes compared with heterozygotes). Null results were noted in studies with sound epidemiological design and conduct (1.06 [0.87-1.29] for arginine homozygotes compared with heterozygotes), and studies in which TP53 genotype was determined from white blood cells (1.06 [0.87-1.29] for arginine homozygotes compared with heterozygotes). Interpretation Subgroup analyses indicated that excess risks were most likely not due to clinical or biological factors, but to errors in study methods. No association was found between cervical cancer and TP53 codon 72 polymorphism when the analysis was restricted to methodologically sound studies. Funding German Research Foundation (DFG).
Tárgyszavak:Orvostudományok Elméleti orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban
p53
cervical cancer
Megjelenés:The Lancet Oncology. - 10 : 8 (2009), p. 772-784. -
További szerzők:Ressing, Meike Koenig, Jochem Abba, Martin C. Agorastos, Theodoros Brenna, Sylvia M. F. Ciotti, Marco Das, B. R. Del, Mistro Annaros Dybikowska, Aleksandra Giuliano, Anna R. Gudleviciene, Zivile Gyllensten, Ulf Haws, Andrea L. F. Helland, Aslaug Herrington, C. Simon Hildesheim, Alan Humbey, Oliver Jee, Sun H. Kim, Jae Weon Madeleine, M. Margaret Menczer, Joseph Ngan, Hextan Y. S. N. Nishikawa, Akira Niwa, Yosimitshu Pegoraro, Rosemary Pillai, M. R. Ranzani, Gulielmina Rezza, Giovanni Rosenthal, Adam N. Roychoudhury, Susanta Saranath, Dhananjaya Schmitt, Virginia M. Sengupta, Sharmila Settheetham-Ishida, Wannapa Shirasawa, Hiroshi Snijders, Peter J. F. Stoler, Mark H. Suárez-Rincón, Angel E. Szarka Krisztina (1971-) (molekuláris biológus, mikrobiológus) Tachezy, Ruth Ueda, Masatsugu Zee, Ate G. J., van der Knebel, Doeberitz Magnus, Von Wu, Ming-Tsang Yamashita, Tsuyoshi Zehbe, Ingeborg Blettner Maria
Internet cím:DOI
elektronikus változat
Borító:

4.

001-es BibID:BIBFORM100577
035-os BibID:(WoS)000610553800056 (Scopus)85098232848
Első szerző:Laubach, Jacob P.
Cím:Efficacy and safety of oral panobinostat plus subcutaneous bortezomib and oral dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma (PANORAMA 3) : an open-label, randomised, phase 2 study / Laubach Jacob P., Schjesvold Fredrik, Mariz Mário, Dimopoulos Meletios A., Lech-Maranda Ewa, Spicka Ivan, Hungria Vania T. M., Shelekhova Tatiana, Abdo Andre, Jacobasch Lutz, Polprasert Chantana, Hájek Roman, Illés Árpád, Wróbel Tomasz, Sureda Anna, Beksac Meral, Goncalves Iara Z., Bladé Joan, Rajkumar S. Vincent, Chari Ajai, Lonial Sagar, Spencer Andrew, Maison-Blanche Pierre, Moreau Philippe, San-Miguel Jesus F., Richardson Paul G.
Dátum:2021
ISSN:1470-2045
Tárgyszavak:Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban
folyóiratcikk
Megjelenés:Lancet Oncology. - 22 : 1 (2021), p. 142-154. -
További szerzők:Schjesvold, Fredrik Mariz, Mário Dimopoulos, Meletios A. Lech-Maranda, Ewa Špička, Ivan Hungria, Vania T. M. Shelekhova, Tatiana Abdo, Andre Jacobasch, Lutz Polprasert, Chantana Hájek, Roman Illés Árpád (1959-) (belgyógyász, haematológus, onkológus) Wróbel, Tomasz Sureda, Anna Beksac, Meral Gonçalves, Iara Z. Bladé, Joan Rajkumar, S. Vincent Chari, Ajai Lonial, Sagar Spencer, Andrew Maison-Blanche, Pierre Moreau, Philippe San-Miguel, Jesus F. Richardson, Paul G.
Internet cím:Szerző által megadott URL
DOI
Intézményi repozitóriumban (DEA) tárolt változat
Borító:

5.

001-es BibID:BIBFORM063328
Első szerző:Thompson, Eric M.
Cím:Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis / Eric M. Thompson, Thomas Hielscher, Eric Bouffet, Marc Remke, Betty Luu, Sridharan Gururangan, Roger E. McLendon, Darell D. Bigner, Eric S. Lipp, Sebastien Perreault, Yoon-Jae Cho, Gerald Grant, Seung-Ki Kim, Ji Yeoun Lee, Amulya A. Nageswara Rao, Caterina Giannini, Kay Ka Wai Li, Ho-Keung Ng, Yu Yao, Toshihiro Kumabe, Teiji Tominaga, Wieslawa A. Grajkowska, Marta Perek-Polnik, David C.Y. Low, Wan Tew Seow, Kenneth T.E. Chang, Jaume Mora, Ian F. Pollack, Ronald L. Hamilton, Sarah Leary, Andrew S. Moore, Wendy J. Ingram, Andrew R. Hallahan, Anne Jouvet, Michelle Fèvre-Montange, Alexandre Vasiljevic, Cecile Faure-Conter, Tomoko Shofuda, Naoki Kagawa, Naoya Hashimoto, Nada Jabado, Alexander G. Weil, Tenzin Gayden, Takafumi Wataya, Tarek Shalaby, Michael Grotzer, Karel Zitterbart, Jaroslav Sterba, Leos Kren, Tibor Hortobágyi, Almos Klekner, Bognár László, Tímea Pócza, Peter Hauser, Ulrich Schüller, Shin Jung, Woo-Youl Jang, Pim J. French, Johan M. Kros, Marie-Lise C. van Veelen, Luca Massimi, Jeffrey R. Leonard, Joshua B. Rubin, Rajeev Vibhakar, Lola B. Chambless, Michael K. Cooper, Reid C. Thompson, Claudia C. Faria, Alice Carvalho, Sofia Nunes, José Pimentel, Xing Fan, Karin M. Muraszko, Enrique López-Aguilar, David Lyden, Livia Garzia, David J. H. Shih, Noriyuki Kijima, Christian Schneider, Jennifer Adamski, Paul A. Northcott, Marcel Kool, David T. W. Jones, Jennifer A. Chan, Ana Nikolic, Maria Luisa Garre, Erwin G. Van Meir, Satoru Osuka, Jeffrey J. Olson, Arman Jahangiri, Brandyn A. Castro, Nalin Gupta, William A. Weiss, Iska Moxon-Emre, Donald J. Mabbott, Alvaro Lassaletta, Cynthia E. Hawkins, Uri Tabori, James Drake, Abhaya Kulkarni, Peter Dirks, James T. Rutka, Andrey Korshunov, Stefan M. Pfister, Roger J. Packer, Vijay Ramaswamy, Michael D. Taylor
Dátum:2016
ISSN:1470-2045
Tárgyszavak:Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban
Megjelenés:Lancet Oncology 17 : 4 (2016), p. 484-495. -
További szerzők:Hielscher, Thomas Bouffet, Eric Remke, Marc Luu, Betty Gururangan, Sridharan McLendon, Roger E. Bigner, Darell Lipp, Eric S. Perreault, Sebastien Cho, Yoon-Jae Grant, Gerald Kim, Seung-Ki Lee, Ji-Yeoun Rao, Amulya A. Nageswara Giannini, Caterina Li, Kay Ka Wai Ng, Ho-Keung Yao, Yu Kumabe, Toshihiro Tominaga, Teiji Grajkowska, Wieslawa A. Perek-Polnik, Marta Low, David C.Y. Seow, Wan Tew Chang, Kenneth T.E. Mora, Jaume Pollack, Ian F. Hamilton, Ronald L. Leary, Sarah Moore, Andrew S. Ingram, Wendy J. Hallahan, Andrew R. Jouvet, Anne Fèvre-Montange, Michelle Vasiljevic, Alexandre Faure-Conter, Cecile Shofuda, Tomoko Kagawa, Naoki Hashimoto, Naoya Jabado, Nada Weil, Alexander G. Gayden, Tenzin Wataya, Takafumi Shalaby, Tarek Grotzer, Michael Zitterbart, Karel Sterba, Jaroslav Kren, Leos Hortobágyi Tibor (1965-) (patológus) Klekner Álmos (1970-) (idegsebész) Bognár László (1958-) (idegsebész, gyermekidegsebész) Pócza Tímea Hauser Péter Schüller, Ulrich Jung, Shin Jang, Woo-Youl French, Pim J. Kros, Johan M. van Veelen, Marie-Lise C. Massimi, Luca Leonard, Jeffrey R. Rubin, Joshua B. Vibhakar, Rajeev Chambless, Lola B. Cooper, Michael K. Thompson, Reid C. Faria, Claudia C. Carvalho, Alice Nunes, Sofia Pimentel, José Fan, Xing Muraszko, Karin M. Lopez-Aguilar, Enrique Lyden, David Garzia, Livia Shih, David J. H. Kijima, Noriyuki Schneider, Christian Adamski, Jennifer Northcott, Paul A. Kool, Marcel Jones, David T. W. Chan, Jennifer A. Nikolic, Ana Garre, Maria Luisa van Meir, Erwin G. Osuka, Satoru Olson, Jeffrey J. Jahangiri, Arman Castro, Brandyn A. Gupta, Nalin Weiss, William A. Moxon-Emre, Iska Mabbott, Donald J. Lassaletta, Alvaro Hawkins, Cynthia E. Tabori, Uri Drake, James Kulkarni, Abhaya Dirks, Peter Rutka, James T. Korshunov, Andrey Pfister, Stefan M. Packer, Roger J. Ramaswamy, Vijay Taylor, Michael D.
Internet cím:Szerző által megadott URL
DOI
Intézményi repozitóriumban (DEA) tárolt változat
Borító:

6.

001-es BibID:BIBFORM063337
Első szerző:Torchia, Jonathon
Cím:Molecular subgroups of atypical teratoid rhabdoid tumours in children: an integrated genomic and clinicopathological analysis / Jonathon Torchia, Daniel Picard, Lucie Lafay-Cousin, Cynthia E. Hawkins, Seung-Ki Kim, Louis Letourneau, Young-Shin Ra, King Ching Ho, Tiffany Sin Yu Chan, Patrick Sin-Chan, Christopher P. Dunham, Stephen Yip, Ho-Keung Ng, Jian-Qiang Lu, Steffen Albrecht, José Pimentel, Jennifer A. Chan, Gino R. Somers, Maria Zielenska, Claudia C. Faria, Lucia Roque, Berivan Baskin, Diane Birks, Nick Foreman, Douglas Strother, Almos Klekner, Miklos Garami, Peter Hauser, Tibor Hortobágyi, Laszló Bognár, Beverly Wilson, Juliette Hukin, Anne-Sophie Carret, Timothy E. Van Meter, Hideo Nakamura, Helen Toledano, Iris Fried, Daniel Fults, Takafumi Wataya, Chris Fryer, David D. Eisenstat, Katrin Scheineman, Donna Johnston, Jean Michaud, Shayna Zelcer, Robert Hammond, David A. Ramsay, Adam J. Fleming, Rishi R. Lulla, Jason R. Fangusaro, Nongnuch Sirachainan, Noppadol Larbcharoensub, Suradej Hongeng, Muhammad Abrar Barakzai, Alexandre Montpetit, Derek Stephens, Richard G. Grundy, Ulrich Schüller, Theodore Nicolaides, Tarik Tihan, Joanna Phillips, Michael D. Taylor, James T. Rutka, Peter Dirks, Gary D. Bader, Monika Warmuth-Metz, Stefan Rutkowski, Torsten Pietsch, Alexander R. Judkins, Nada Jabado, Eric Bouffet, Annie Huang
Dátum:2015
ISSN:1470-2045
Tárgyszavak:Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban
Megjelenés:Lancet Oncology. - 16 : 5 (2015), p. 569-582. -
További szerzők:Picard, Daniel Lafay-Cousin, Lucie Hawkins, Cynthia E. Kim, Seung-Ki Letourneau, Louis Ra, Young-Shin Ho, King Ching Chan, Tiffany Sin Yu Sin-Chan, Patrick Dunham, Christopher P. Yip, Stephen Ng, Ho-Keung Lu, Jian-Qiang Albrecht, Stephen Pimentel, José Chan, Jennifer A. Somers, Gino R. Zielenska, Maria Faria, Claudia C. Roque, Lucia Baskin, Berivan Birks, Diane Foreman, Nicholas K. Strother, Douglas Klekner Álmos (1970-) (idegsebész) Garami Miklós Hauser Péter Hortobágyi Tibor (1965-) (patológus) Bognár László (1958-) (idegsebész, gyermekidegsebész) Wilson, Beverly Hukin, Juliette Carret, Anne-Sophie van Meter, Timothy E. Nakamura, Hideo Toledano, Helen Fried, Iris Fults, Daniel Wataya, Takafumi Fryer, Chris Eisenstat, David D. Scheineman, Katrin Johnston, Donna Michaud, Jean Zelcer, Shayna Hammond, Robert Ramsay, David A. Fleming, Adam Lulla, Rishi R. Fangusaro, Jason R. Sirachainan, Nongnuch Larbcharoensub, Noppadol Hongeng, Suradej Barakzai, Muhammad Abrar Montpetit, Alexandre Stephens, Derek Grundy, Richard G. Schüller, Ulrich Nicolaides, Theodore Tihan, Tarik Phillips, Joanna J. Taylor, Michael D. Rutka, James T. Dirks, Peter Bader, Gary D. Warmuth-Metz, Monika Rutkowski, Stefan Pietsch, Torsten Judkins, Alexander R. Jabado, Nada Bouffet, Eric Huang, Annie
Internet cím:Szerző által megadott URL
DOI
Intézményi repozitóriumban (DEA) tárolt változat
Borító:

7.

001-es BibID:BIBFORM070024
Első szerző:Zelenetz, Andrew D.
Cím:Idelalisib or placebo in combination with bendamustine and rituximab in patients with relapsed or refractory chronic lymphocytic leukaemia : interim results from a phase 3, randomised, double-blind, placebo-controlled trial / Andrew D. Zelenetz, Jacqueline C. Barrientos, Jennifer R. Brown, Bertrand Coiffier, Julio Delgado, Miklós Egyed, Paolo Ghia, Árpád Illés, Wojciech Jurczak, Paula Murlton, Marco Montillo, Franck Morschhauser, Alexander S. Pristupa, Tadeusz Robak, Jeff P. Sharman, David Simpson, Lukás Smolej, Eugen Tausch, Adeboye H. Adewoye, Lyndah K. Dreiling, Yeonhee Kim, Stephan Stilgenbaur, Peter Hillmen
Dátum:2017
ISSN:1470-2045
Tárgyszavak:Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban
Megjelenés:Lancet Oncology 18 (2017), p. 297-311. -
További szerzők:Barrientos, Jacqueline C. Brown, Jennifer R. Coiffier, Bertrand Delgado, Julio Egyed Miklós Ghia, Paolo Illés Árpád (1959-) (belgyógyász, haematológus, onkológus) Jurczak, Wojciech Murlton, Paula Montillo, Marco Morschhauser, Franck Pristupa, Alexander S. Robak, Tadeusz Sharman, Jeff P. Simpson, David Smolej, Lukás Tausch, Eugen Adewoye, Adeboye H. Dreiling, Lyndah K. Kim, Yeonhee Stilgenbaur, Stephan Hillmen, Peter
Internet cím:Intézményi repozitóriumban (DEA) tárolt változat
Borító:
Rekordok letöltése1 
Corvina könyvtári katalógus v8.2.27 © 2023 Monguz kft. Minden jog fenntartva.